ADVERTISEMENT

3.48 Lakh New COVID Cases, 4,205 Deaths in India; Tally at 2.33 Cr

Catch all the updates on the coronavirus outbreak here. 

Updated
India
1 min read
A medic collects samples for COVID-19 testing in New Delhi. Image used for representational purposes. 
i

India on Wednesday, 12 May, reported 3,48,421 new coronavirus cases, taking the tally in the country to 2,33,40,938. The death toll increased by 4,205 to 2,54,197.

According to the Union Health Ministry data, there are currently 37,04,099 active cases across the country, while 1,93,82,642 patients have been discharged so far, with 3,55,338 discharges reported in the last 24 hours.

Active cases dropped by 11,122 on Wednesday.

Snapshot
  • Delhi on Tuesday reported 12,481 new coronavirus cases, with a positivity rate of 17.76 percent, and 347 deaths
  • Uttar Pradesh reported 20,463 new infections and 306 fatalities on Tuesday
  • Bharat Biotech’s Covaxin has been recommended by an expert panel for phase II and III clinical trials on 2 to 18-year-olds, reports said on Tuesday

(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)

3:26 PM , 12 May

Over 24 Lakh Vaccine Doses Administered on 11 May: Centre

Over 24 lakh vaccine doses were administered on 11 May, the Union Health Ministry said on Wednesday.

ADVERTISEMENT
10:28 AM , 12 May

3.48 Lakh New COVID Cases, 4,205 Deaths in India; Tally at 2.33 Cr

India on Wednesday, 12 May, reported 3,48,421 new coronavirus cases, taking the tally in the country to 2,33,40,938. The death toll increased by 4,205 to 2,54,197.

According to the Union Health Ministry data, there are currently 37,04,099 active cases across the country, while 1,93,82,642 patients have been discharged so far, with 3,55,338 discharges reported in the last 24 hours. Active cases dropped by 11,122 on Wednesday.

10:08 AM , 12 May
KEY EVENT

Covaxin Recommended for Phase II/III Clinical Trials on 2-18 Age Group

Bharat Biotech’s Covaxin has been recommended by an expert panel for phase II and III clinical trials on 2 to 18-year-olds, reports said on Tuesday.

ADVERTISEMENT
10:08 AM , 12 May

19.83 Lakh Samples Tested for COVID on Tuesday: ICMR

As many as 30,75,83,991 samples have been tested for COVID-19 up to 11 May, of which 19,83,804 samples were tested on Tuesday, the Indian Council of Medical Research (ICMR) said.

Published: 12 May 2021, 10:08 AM IST
ADVERTISEMENT
Stay Updated

Subscribe To Our Daily Newsletter And Get News Delivered Straight To Your Inbox.

Join over 120,000 subscribers!
ADVERTISEMENT